Long-lasting protective effect of slow-release theophylline on asthma induced by ultrasonically nebulized distilled water.
We investigated the intensity and duration of the effect of a single dose of slow-release theophylline on bronchial hyperresponsiveness to ultrasonically nebulized distilled water in asthma. In six subjects with a history of mild asthma, we measured airway responsiveness to ultrasonically nebulized distilled water and serum theophylline at 4, 8, and 12 hours after treatment with placebo or slow-release theophylline (10 +/- 1 mg/kg, orally). To assess bronchial responsiveness, dose-response curves were established by plotting the baseline value of FEV1 and the largest FEV1 after each doubling dose of nebulized distilled water against the dose of nebulized water. The degree of bronchoconstriction induced by ultrasonically nebulized distilled water was significantly inhibited at 4, 8, and 12 hours after treatment with theophylline, at serum levels of 14.8 +/- 4.6, 14.4 +/- 2.8, and 12.0 +/- 2.5 micrograms/mL theophylline (mean +/- SD). Tremor occurred in three patients and was associated with nausea, epigastric pain, and tachycardia in one of them. We conclude that a single dose of slow-release theophylline has a prolonged protective effect on bronchoconstriction induced by ultrasonically nebulized distilled water, but in some subjects is associated with side effects that limit its clinical usefulness.
D001249:Asthma / Q000209:etiology / Q000517:prevention & control*; D001986:Bronchial Spasm / Q000209:etiology; D003692:Delayed-Action Preparations; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D012119:Respiration; D013806:Theophylline / Q000008:administration & dosage*; D014465:Ultrasonics; D014867:Water / Q000008:administration & dosage
D003692:Delayed-Action Preparations; D014867:Water; D013806:Theophylline